Chai Discovery
Backed by
Chai has built an AI model that its founders claim can transform the process of designing molecules that bind to proteins and influence their function. The company aims to enable the creation of de novo antibodies and, ultimately, drugs.
Explore similar companies to Chai Discovery
Edison
The AI platform for scientific R&D.
Biotech · Seed · Onsite · Based in San Francisco
Science
A brighter tomorrow enabled by neural engineering.
Biotech · Series C · Onsite · Based in Alameda
Loyal
Extending the lifespan of dogs.
Biotech · Series C · Remote · Based in San Francisco
Kingdom Supercultures
Natural functional ingredients that actually work.
Biotech · Series A · Onsite · Based in New York
CuspAI
Frontier AI for breakthrough materials.
Biotech · Series A · Remote · Based in London
Cortical Labs
Lab-grown neurons with silicon chips.
Biotech · Seed · Remote · Based in Melbourne
Convoke
AI-native OS for drug development.
Biotech · Seed · Onsite · Based in San Francisco
Converge Bio
Accelerating therapeutic breakthroughs with AI.
Biotech · Series A · Remote · Based in Tel Aviv
Mantis Biotech
Infrastructure for human-in-computer models.
Biotech · Seed · Onsite · Based in New York
Industries
Investors
Cities